Opus Capital Group LLC held its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,450 shares of the pharmacy operator’s stock at the close of the second quarter. Opus Capital Group LLC’s holdings in Walgreens Boots Alliance were worth $583,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of WBA. KBC Group NV boosted its holdings in shares of Walgreens Boots Alliance by 8.2% during the second quarter. KBC Group NV now owns 135,664 shares of the pharmacy operator’s stock worth $10,624,000 after acquiring an additional 10,267 shares during the period. First Personal Financial Services boosted its holdings in shares of Walgreens Boots Alliance by 153.1% during the second quarter. First Personal Financial Services now owns 5,857 shares of the pharmacy operator’s stock worth $459,000 after acquiring an additional 3,543 shares during the period. Hartland & Co. LLC boosted its holdings in shares of Walgreens Boots Alliance by 1.9% during the second quarter. Hartland & Co. LLC now owns 15,130 shares of the pharmacy operator’s stock worth $1,185,000 after acquiring an additional 275 shares during the period. Ballentine Partners LLC boosted its holdings in shares of Walgreens Boots Alliance by 8.7% during the second quarter. Ballentine Partners LLC now owns 3,825 shares of the pharmacy operator’s stock worth $307,000 after acquiring an additional 305 shares during the period. Finally, Gamco Investors INC. ET AL boosted its holdings in shares of Walgreens Boots Alliance by 4.5% during the second quarter. Gamco Investors INC. ET AL now owns 464,409 shares of the pharmacy operator’s stock worth $36,368,000 after acquiring an additional 19,795 shares during the period. Institutional investors and hedge funds own 60.16% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 67.56 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $67.40 and a 1-year high of $89.69. The firm has a 50-day moving average of $78.27 and a 200 day moving average of $80.63. The stock has a market cap of $72.30 billion, a price-to-earnings ratio of 17.06 and a beta of 1.25.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock repurchase program on Thursday, June 29th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance, Inc. (WBA) Stake Held by Opus Capital Group LLC” was originally posted by Daily Political and is the property of of Daily Political. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/10/15/walgreens-boots-alliance-inc-wba-stake-held-by-opus-capital-group-llc.html.

Several brokerages recently issued reports on WBA. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Saturday, June 24th. Needham & Company LLC initiated coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, June 27th. They set a “hold” rating for the company. Goldman Sachs Group, Inc. (The) restated a “neutral” rating and set a $77.00 price objective (down from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Pivotal Research set a $85.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Sunday, July 2nd. Finally, Morgan Stanley restated an “overweight” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. One analyst has rated the stock with a sell rating, seven have issued a hold rating and fourteen have given a buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and an average target price of $90.18.

In other news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.